1,3,3-三甲基-1,3-二氢-2H-吡咯并[2,3-b]吡啶-2-酮 | 127555-22-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯并吡啶类
• 中文名称: 1,3,3-三甲基-1,3-二氢-2H-吡咯并[2,3-b]吡啶-2-酮
• 英文名称: 1,3,3-trimethyl-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
• 英文别名: 1,3,3-trimethylpyrrolo[2,3-b]pyridin-2-one
• CAS: 127555-22-0
• 化学式: C₁₀H₁₂N₂O
• 分子量: 176.218
• InChiKey: MDYXRVRZZPXLLR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  33.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  在 fac-tris(2-phenylpyridinato-N,C2')iridium(III) 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 丙酮 为溶剂， 反应 60.0h， 以65%的产率得到1,3,3-三甲基-1,3-二氢-2H-吡咯并[2,3-b]吡啶-2-酮
  参考文献：
  名称：

  可见光光氧化还原催化芳基碘的分子内1，5-H转移反应：一种合成天然产物支架的简明方法

  摘要：

  描述了通过光催化由未活化的芳基碘化物产生的芳基的分子内1，5-H转移反应。这种转变的特点是操作简便，产量高，反应温和...

  DOI：

  10.1039/c6cc02007k

文献信息

• Heterobicyclic compounds having antiinflammatory activity
  申请人：Schering Corporation

  公开号：US05182289A1

  公开（公告）日：1993-01-26

  Heterobicyclic and heterocyclic intermediate compounds and their use in treating inflammation, hyperproliferative skin conditions such as psoriasis and allergy are disclosed.

  异双环和杂环中间化合物及其在治疗炎症、过度增生性皮肤病（如牛皮癣）和过敏中的应用被揭示。
• 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES
  申请人：Furet Pascal

  公开号：US20140005163A1

  公开（公告）日：2014-01-02

  The invention relates to the use of 1H-imidazo[4,5-c]quinolinone derivatives and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1H-imidazo[4,5-c]quinolinone derivatives for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1H-imidazo[4,5-c]quinolinone derivatives to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1H-imidazo[4,5-c]quinolinone derivative, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1H-imidazo[4,5-c]quinolinone derivatives; and a process for the preparation of the novel 1H-imidazo[4,5-c]quinolinone derivatives.

  本发明涉及使用1H-咪唑[4,5-c]喹啉酮衍生物及其盐治疗蛋白质和/或脂质激酶依赖性疾病，并用于制备治疗该类疾病的药物制剂；使用1H-咪唑[4,5-c]喹啉酮衍生物治疗蛋白质和/或脂质激酶依赖性疾病；一种治疗该类疾病的方法，包括向温血动物，特别是人类，给予1H-咪唑[4,5-c]喹啉酮衍生物；包含1H-咪唑[4,5-c]喹啉酮衍生物的药物制剂，特别用于治疗蛋白质和/或脂质激酶依赖性疾病；新型1H-咪唑[4,5-c]喹啉酮衍生物；以及制备新型1H-咪唑[4,5-c]喹啉酮衍生物的方法。
• 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
  申请人：FURET Pascal

  公开号：US20100317657A1

  公开（公告）日：2010-12-16

  The invention relates to the use of 1H-imidazo[4,5-c]quinolinone derivatives and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1H-imidazo[4,5-c]quinolinone derivatives for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1H-imidazo[4,5-c]quinolinone derivatives to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1H-imidazo[4,5-c]quinolinone derivative, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1H-imidazo[4,5-c]quinolinone derivatives; and a process for the preparation of the novel 1H-imidazo[4,5-c]quinolinone derivatives.

  本发明涉及使用1H-咪唑[4,5-c]喹啉酮衍生物及其盐在治疗蛋白质和/或脂质激酶依赖性疾病和制造治疗该类疾病的药物制剂；1H-咪唑[4,5-c]喹啉酮衍生物用于治疗蛋白质和/或脂质激酶依赖性疾病；一种治疗上述疾病的方法，包括向温血动物，特别是人类，给予1H-咪唑[4,5-c]喹啉酮衍生物；包括1H-咪唑[4,5-c]喹啉酮衍生物的药物制剂，特别用于治疗蛋白质和/或脂质激酶依赖性疾病；新型1H-咪唑[4,5-c]喹啉酮衍生物；以及制备新型1H-咪唑[4,5-c]喹啉酮衍生物的方法。
• N-Heterocyclic Nitreniums Can Be Employed as Photoredox Catalysts for the Single-Electron Reduction of Aryl Halides
  作者：Kun-Quan Chen、Bei-Bei Zhang、Zhi-Xiang Wang、Xiang-Yu Chen

  DOI：10.1021/acs.orglett.2c01702

  日期：2022.7.1

  nitrenium (NHN) salts, the analogues of N-heterocyclic carbenes, have attracted considerable interest. However, relatively little is known about their catalytic ability beyond their Lewis acid catalysis. Herein, we describe that NHNs can serve as catalytic electron acceptors for charge transfer complex photoactivations. We showcase that, under blue light irradiation, the NHN salts could catalyze the

  N-杂环氮 (NHN) 盐是 N-杂环卡宾的类似物，引起了相当大的兴趣。然而，对于它们在路易斯酸催化之外的催化能力知之甚少。在这里，我们描述了 NHNs 可以作为电荷转移复合物光活化的催化电子受体。我们展示了在蓝光照射下，NHN盐可以催化芳基卤化物生成芳基自由基。
• Photoinduced halogen-bonding enabled synthesis of oxindoles and isoindolinones from aryl iodides
  作者：Wen-Xin Tang、Kun-Quan Chen、De-Qun Sun、Xiang-Yu Chen

  DOI：10.1039/d2ob01818g

  日期：——

  halogen bonding (XB) for the generation of aryl radicals from aryl halides under blue light irradiation and applied it in radical generation/1,5-hydrogen-atom transfer/radical cyclization cascade reactions for the synthesis of oxindoles and isoindolinones. On the basis of experimental studies, we propose that DBU can serve as a suitable XB acceptor with aryl halides for the formation of a photoactive

  我们报道了卤键 (XB) 在蓝光照射下从芳基卤化物生成芳基自由基的用途，并将其应用于自由基生成/1,5-氢原子转移/自由基环化级联反应以合成羟吲哚和异吲哚啉酮. 在实验研究的基础上，我们提出 DBU 可以作为合适的 XB 受体与芳基卤化物形成光活性电子供体和受体复合物。